PACB

Neutral

Pacific Biosciences (PACB) Reports Q1 EPS

Pacific Biosciences (NASDAQ:PACB) reported Q1 EPS of (12c), narrowly beating the consensus estimate of (13c), but revenue of $37.18M fell short of the...

Insider Monkey 21 hours ago 0

Bullish

[10-Q] PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Quarterly Earnings Report

Pacific Biosciences of California, Inc. (PACB) reported Q1 2026 revenue of $37.2 million, flat year-over-year, with higher consumable sales offsetting...

Stock Titan 4 days ago 0

Bullish

Pacific Biosciences of California presents new AAV workflow to reduce partial snapback genomes

Pacific Biosciences of California has introduced a new heat-then-extract workflow for adeno-associated virus (AAV) genome analysis. This innovative me...

Traders Union 1 week ago 0

Neutral

Sequencing performance advances drive Pacific Biosciences of California to revamp SMRT Cell 101 resource

Pacific Biosciences of California has updated its SMRT Cell Sequencing 101 guide to reflect the latest advancements in its PacBio HiFi sequencing, inc...

Traders Union 2 weeks ago 0

Bullish

Pacific Biosciences of California reveals unified approach to structural variant detection in cancer research

Pacific Biosciences of California (PacBio) is advancing cancer drug research and development by introducing its HiFi sequencing technology, which offe...

Traders Union 3 weeks ago 0